When was SIDAM founded?

SIDAM was founded in 1991 and raised its 1st funding round 29 years after it was founded.

Where is SIDAM located?

SIDAM is headquartered in Mirandola, Italy.

How many employees does SIDAM have?

As of Jul 31, 2026, the latest employee count at SIDAM is 108.

Is SIDAM a funded company?

SIDAM is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Aug 2020.

When was the latest funding round of SIDAM?

SIDAM's latest funding was a $***** Grant (prize money) round on Dec 01, 2020, with participation from 1 investor.

Where does SIDAM rank among its competitors?

SIDAM ranks 132nd amongst 1127 active competitors, of which 72 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Caidya, which secured $165M in Jan, 2025.

Who are the top competitors of SIDAM?

SIDAM's top competitors include WuXi AppTec, ANI Pharmaceuticals and EVERSANA. Among them, Caidya secured the most recent funding round in January, 2025.

SIDAM - 2026 Company Profile, Team, Funding & Competitors

Company Details

Sidam manufactures infusion systems for hospitals. For the resuscitation departments, the company manufactures both medical devices, including the Nutrient, and electromedical equipment, or the optivent. For imaging diagnostics, we make disposable medical devices, electromedical equipment, or thermostatic cell.

Website: sidamgroup.com
Email ID: *****@sidamit.it
Phone Number: +39 **********

Key Metrics

Founded Year

1991

Location

Mirandola, Italy

Stage

Acquired

Latest Funding Round

Grant (prize money), Dec 01, 2020, $*****

Investors

Berrier Capital & 1 more

Ranked

132^nd among 1127 active competitors

Employee Count

108 as on Jul 31, 2026

Similar Companies

Mizuho OSI & 56 more

Exit Details

Acquired by Mandarin Capital Partners (Sep 03, 2020)

View SIDAM's full profile

SIDAM got acquired by Mandarin Capital Partners on Sep 03, 2020.

Click here to take a look at SIDAM's acquisition in detail

SIDAM has raised funding over 2 rounds. Its first funding round was on Aug 2020. Its latest funding round was a Grant (prize money) round on Dec 01, 2020 for $*****. 1 investor participated in its latest round. SIDAM has 2 institutional investors.

Here is the list of recent funding rounds of SIDAM:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 01, 2020	3850831	Grant (prize money)	7276493	7412703	4841823	8504067
Aug 2020	8098619	Seed	7145455	9954033	3900118	Mindful Capital Partners

Access funding benchmarks and valuations. Sign up today!

View details of SIDAM's funding rounds and investors

The founders of SIDAM is Graziano Azzolini.

Here are the details of SIDAM's key team members:

Graziano Azzolini: Founder of SIDAM.

View details of SIDAM's Founder profiles and Board Members

SIDAM's employee count trend

SIDAM has 108 employees as of Jul 26. Here is SIDAM's employee count trend over the years:

Uncover SIDAM's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SIDAM include WuXi AppTec, ANI Pharmaceuticals and EVERSANA. Here is the list of Top 10 competitors of SIDAM, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	WuXi AppTec 2000, Shanghai (China), Public	Provider of CRO and CDMO services	$40M	Synergis Capital, HongShan & 27 others	79/100
2nd	ANI Pharmaceuticals 1996, Baudette (United States), Public	Manufacturer of pharmaceutical products, including extended-release capsules and immediate-release tablets	-	Ampersand Capital, US Bank & 4 others	64/100
3rd	EVERSANA 2014, Milwaukee (United States), Funding Raised	Provider of consulting services for drug pricing access, reimbursement, and regulatory support	-	North Sky Capital, ACE & Company & 2 others	63/100
4th	Ipsen 1929, Paris (France), Public	Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes	-	Digital Pharma Lab, Qualium Investissement ... & 2 others	63/100
5th	Zuellig Pharma 1992, Singapore (Singapore), Funding Raised	Provider of clinical research, quality management, logistics, and clinical trial supply services	-	Temasek	61/100
6th	Eurofins Scientific 1987, Luxembourg (Luxembourg), Public	Provider of laboratory testing services and CRO contract research services	-	CDPQ, Holland Capital & 1 others	61/100
7th	Precision Medicine Group 2012, Bethesda (United States), Late Stage	Provider of clinical research, development, and commercialization services for life sciences	$532M	TPG, Blackstone & 7 others	60/100
8th	Curatio healthcare 2005, Chennai (India), Acquired	Provider of market research services for biopharma sector, and dermatology products for cosmetologists	$44.8M	Camel Investment Limited, ChrysCapital & 13 others	59/100
9th	China Medical System 1992, Shenzhen (China), Public	Manufacturer of generic formulations	-	CMS Ventures	55/100
10th	Caidya 2003, Morrisville (United States), Series C	CRO focused on clinical development for phases II & III clinical trials and regulatory affair services	$373M	Qiming Venture Partners, Fidelity Investments ... & 22 others	54/100
132nd	SIDAM 1991, Mirandola (Italy), Acquired	Manufacturer of infusion system for hospitals	-	Berrier Capital, Europa	35/100